Induction of human interferon gene expression is associated with a nuclear factor that interacts with the NF-kappa B site of the human immunodeficiency virus enhancer.

PubWeight™: 1.90‹?› | Rank: Top 3%

🔗 View Article (PMC 250725)

Published in J Virol on June 01, 1989

Authors

J Hiscott1, D Alper, L Cohen, J F Leblanc, L Sportza, A Wong, S Xanthoudakis

Author Affiliations

1: Lady Davis Institute for Medical Research, Sir Mortimer B. Davis-Jewish General Hospital, Montreal, Quebec, Canada.

Articles citing this

Influenza A virus NS1 protein prevents activation of NF-kappaB and induction of alpha/beta interferon. J Virol (2000) 5.44

Deficient cytokine signaling in mouse embryo fibroblasts with a targeted deletion in the PKR gene: role of IRF-1 and NF-kappaB. EMBO J (1997) 3.34

Purification and cloning of interferon-stimulated gene factor 2 (ISGF2): ISGF2 (IRF-1) can bind to the promoters of both beta interferon- and interferon-stimulated genes but is not a primary transcriptional activator of either. Mol Cell Biol (1990) 3.31

Comparison of two host cell range variants of feline immunodeficiency virus. J Virol (1990) 2.98

Characterization of a functional NF-kappa B site in the human interleukin 1 beta promoter: evidence for a positive autoregulatory loop. Mol Cell Biol (1993) 2.90

Human tumor necrosis factor alpha gene regulation by virus and lipopolysaccharide. Proc Natl Acad Sci U S A (1990) 2.63

A novel interferon-inducible domain: structural and functional analysis of the human interferon regulatory factor 1 gene promoter. Mol Cell Biol (1993) 2.32

Mice devoid of interferon regulatory factor 1 (IRF-1) show normal expression of type I interferon genes. EMBO J (1994) 2.27

Constitutive expression of an ISGF2/IRF1 transgene leads to interferon-independent activation of interferon-inducible genes and resistance to virus infection. J Virol (1992) 1.77

A striking similarity in the organization of the E-selectin and beta interferon gene promoters. Mol Cell Biol (1994) 1.75

Structure and regulation of the human interferon regulatory factor 1 (IRF-1) and IRF-2 genes: implications for a gene network in the interferon system. Mol Cell Biol (1994) 1.74

A multiple cytokine- and second messenger-responsive element in the enhancer of the human interleukin-6 gene: similarities with c-fos gene regulation. Mol Cell Biol (1989) 1.70

Human tumor necrosis factor alpha gene regulation in phorbol ester stimulated T and B cell lines. J Exp Med (1991) 1.68

Identification of the rel family members required for virus induction of the human beta interferon gene. Mol Cell Biol (1995) 1.66

Induction of type I interferon genes and interferon-inducible genes in embryonal stem cells devoid of interferon regulatory factor 1. Proc Natl Acad Sci U S A (1993) 1.58

Viral induction of the human beta interferon promoter: modulation of transcription by NF-kappa B/rel proteins and interferon regulatory factors. J Virol (1994) 1.51

An ATF/CREB binding site is required for virus induction of the human interferon beta gene [corrected]. Proc Natl Acad Sci U S A (1992) 1.49

Synergism between distinct enhanson domains in viral induction of the human beta interferon gene. Mol Cell Biol (1990) 1.46

Hepatitis B virus transactivator MHBst: activation of NF-kappa B, selective inhibition by antioxidants and integral membrane localization. EMBO J (1992) 1.43

Postinduction repression of the beta-interferon gene is mediated through two positive regulatory domains. Proc Natl Acad Sci U S A (1990) 1.37

The SV40 TC-II(kappa B) enhanson binds ubiquitous and cell type specifically inducible nuclear proteins from lymphoid and non-lymphoid cell lines. EMBO J (1989) 1.34

Inborn errors of anti-viral interferon immunity in humans. Curr Opin Virol (2011) 1.31

Inducible processing of interferon regulatory factor-2. Mol Cell Biol (1992) 1.29

The SV40 TC-II(kappa B) and the related H-2Kb enhansons exhibit different cell type specific and inducible proto-enhancer activities, but the SV40 core sequence and the AP-2 binding site have no enhanson properties. EMBO J (1989) 1.26

Multimerization of AAGTGA and GAAAGT generates sequences that mediate virus inducibility by mimicking an interferon promoter element. Proc Natl Acad Sci U S A (1991) 1.23

Stimulation of interferon and cytokine gene expression by imiquimod and stimulation by Sendai virus utilize similar signal transduction pathways. Mol Cell Biol (1995) 1.15

Interferon-beta promoters contain a DNA element that acts as a position-independent silencer on the NF-kappa B site. EMBO J (1993) 1.14

The same target sequences are differentially important for activation of the interleukin 2 receptor alpha-chain gene in two distinct T-cell lines. Proc Natl Acad Sci U S A (1990) 1.13

Cell-specific differences in activation of NF-kappa B regulatory elements of human immunodeficiency virus and beta interferon promoters by tumor necrosis factor. J Virol (1990) 1.10

Coordinate enhancement of cytokine gene expression in human immunodeficiency virus type 1-infected promonocytic cells. J Virol (1990) 1.09

Distinct activation of murine interferon-alpha promoter region by IRF-1/ISFG-2 and virus infection. Nucleic Acids Res (1992) 1.05

Chronic human immunodeficiency virus type 1 infection stimulates distinct NF-kappa B/rel DNA binding activities in myelomonoblastic cells. J Virol (1993) 1.03

Activity and interleukin 1 responsiveness of SV40 enhancer motifs in a rodent immature T cell line. EMBO J (1990) 0.91

Action of spontaneously produced beta interferon in differentiation of embryonal carcinoma cells through an autoinduction mechanism. Mol Cell Biol (1993) 0.88

Production of interferons and beta-chemokines by placental trophoblasts of HIV-1-infected women. Infect Dis Obstet Gynecol (2001) 0.85

Two distinct pathways of interferon induction as revealed by 2-aminopurine. Nucleic Acids Res (1992) 0.82

Constitutive production of alpha and beta interferons in mutant human cell lines. J Virol (1994) 0.79

Identification of distal silencing elements in the murine interferon-A11 gene promoter. Biochem J (1996) 0.78

CD95 Signaling Inhibits B Cell Receptor-Mediated Gammaherpesvirus Replication in Apoptosis-Resistant B Lymphoma Cells. J Virol (2016) 0.75

Articles cited by this

Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem (1987) 281.19

A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology (1973) 127.36

Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol Cell Biol (1982) 116.75

Mapping of RNA by a modification of the Berk-Sharp procedure: the 5' termini of 15 S beta-globin mRNA precursor and mature 10 s beta-globin mRNA have identical map coordinates. Nucleic Acids Res (1979) 31.23

A gel electrophoresis method for quantifying the binding of proteins to specific DNA regions: application to components of the Escherichia coli lactose operon regulatory system. Nucleic Acids Res (1981) 24.41

Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell (1986) 20.08

An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature (1987) 19.23

I kappa B: a specific inhibitor of the NF-kappa B transcription factor. Science (1988) 16.40

Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism. Cell (1986) 15.30

Regulation of inducible and tissue-specific gene expression. Science (1987) 15.04

Multiple point mutations affecting the simian virus 40 enhancer. Science (1983) 13.69

Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to IFN-beta gene regulatory elements. Cell (1988) 9.04

Interferons and their actions. Annu Rev Biochem (1987) 8.36

Molecular cloning of an enhancer binding protein: isolation by screening of an expression library with a recognition site DNA. Cell (1988) 8.00

Biochemistry of interferons and their actions. Annu Rev Biochem (1982) 6.89

Interferon-induced nuclear factors that bind a shared promoter element correlate with positive and negative transcriptional control. Genes Dev (1988) 6.08

Production of high-titered interferon in cultures of human diploid cells. Antimicrob Agents Chemother (1972) 5.86

A high-efficiency HeLa cell nuclear transcription extract. DNA (1988) 5.81

The human beta-interferon gene enhancer is under negative control. Cell (1986) 5.61

The same inducible nuclear proteins regulates mitogen activation of both the interleukin-2 receptor-alpha gene and type 1 HIV. Cell (1988) 5.33

alpha-Interferon-induced transcription of HLA and metallothionein genes containing homologous upstream sequences. Nature (1985) 5.30

Two transcription factors, NF-kappa B and H2TF1, interact with a single regulatory sequence in the class I major histocompatibility complex promoter. Proc Natl Acad Sci U S A (1988) 4.83

Human beta-interferon gene expression is regulated by an inducible enhancer element. Cell (1985) 4.68

Activation of the human beta-interferon gene requires an interferon-inducible factor. Mol Cell Biol (1986) 4.38

Identification and purification of a human immunoglobulin-enhancer-binding protein (NF-kappa B) that activates transcription from a human immunodeficiency virus type 1 promoter in vitro. Proc Natl Acad Sci U S A (1988) 4.33

Interferon response element of the human gene 6-16. EMBO J (1988) 4.11

Cooperativity and hierarchical levels of functional organization in the SV40 enhancer. Cell (1988) 4.03

Interferon response sequence potentiates activity of an enhancer in the promoter region of a mouse H-2 gene. Nature (1986) 3.73

Delimitation and properties of DNA sequences required for the regulated expression of human interferon-beta gene. Cell (1985) 3.57

Overlapping positive and negative regulatory domains of the human beta-interferon gene. Proc Natl Acad Sci U S A (1988) 3.54

Interferon-beta gene regulation: tandemly repeated sequences of a synthetic 6 bp oligomer function as a virus-inducible enhancer. Cell (1987) 3.51

Detection of factors that interact with the human beta-interferon regulatory region in vivo by DNAase I footprinting. Cell (1986) 3.35

Organization of the murine Mx gene and characterization of its interferon- and virus-inducible promoter. Mol Cell Biol (1988) 3.19

Evidence for a nuclear factor(s), IRF-1, mediating induction and silencing properties to human IFN-beta gene regulatory elements. EMBO J (1988) 3.11

Priming: a nonantiviral function of interferon. J Virol (1971) 2.95

Purification of KBF1, a common factor binding to both H-2 and beta 2-microglobulin enhancers. EMBO J (1987) 2.71

Interferon-induced binding of nuclear factors to promoter elements of the 2-5A synthetase gene. EMBO J (1988) 2.66

A 46-nucleotide promoter segment from an IFN-alpha gene renders an unrelated promoter inducible by virus. Cell (1985) 2.65

Regulation of HIV and HTLV gene expression. Genes Dev (1988) 2.19

Regulation of cytokine gene expression. Annu Rev Immunol (1988) 2.17

Reversible silencing of enhancers by sequences derived from the human IFN-alpha promoter. Cell (1987) 1.87

Regulation of gene expression by interferons: control of H-2 promoter responses. Science (1988) 1.85

The interferon genes. Prog Nucleic Acid Res Mol Biol (1986) 1.85

Differential expression of human interferon genes. Nucleic Acids Res (1984) 1.82

Regulation of interleukin 2 receptor alpha subunit (Tac or CD25 antigen) gene expression: binding of inducible nuclear proteins to discrete promoter sequences correlates with transcriptional activation. Proc Natl Acad Sci U S A (1988) 1.74

Interferon-induced transcription of a major histocompatibility class I gene accompanies binding of inducible nuclear factors to the interferon consensus sequence. Proc Natl Acad Sci U S A (1988) 1.73

Controlled transcription of a human alpha-interferon gene introduced into mouse L cells. Nature (1982) 1.58

A transcriptional enhancer and an interferon-responsive sequence in major histocompatibility complex class I genes. Mol Cell Biol (1986) 1.50

Inducibility of human beta-interferon gene in mouse L-cell clones. Nature (1982) 1.43

Multiple protein-DNA interactions within the human interferon-beta regulatory element. J Biol Chem (1989) 1.28

The effect of priming with interferon on interferon production by two lines of L cells. J Gen Virol (1972) 0.89

trans activation of type 1 interferon promoters by simian virus 40 T antigen. Mol Cell Biol (1988) 0.89

Transient expression of the beta interferon promoter in human cells. Mol Cell Biol (1987) 0.85

Interferon production in human hematopoietic cell lines: response to chemicals and characterization of interferons. J Interferon Res (1982) 0.84

Identification of a nuclear DNA binding protein associated with the interferon-beta upstream regulatory region. J Biol Chem (1987) 0.84

Articles by these authors

(truncated to the top 100)

The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nat Genet (1996) 6.43

Mutation of unique region of Bruton's tyrosine kinase in immunodeficient XID mice. Science (1993) 5.50

Dynamic proteomics of individual cancer cells in response to a drug. Science (2008) 5.43

Ultrastructure of the yeast actin cytoskeleton and its association with the plasma membrane. J Cell Biol (1994) 5.14

Randomised trial of laparoscopic exploration of common bile duct versus postoperative endoscopic retrograde cholangiography for common bile duct stones. Lancet (1998) 5.10

Cerebral mechanisms of word masking and unconscious repetition priming. Nat Neurosci (2001) 5.07

Are children's hospitals an idea whose time has come and gone? CMAJ (1993) 4.70

Hospital foundations raise large amounts of money, but also raise some troublesome issues. CMAJ (1993) 4.60

The impact of role models on medical students. J Gen Intern Med (1997) 3.99

Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte. Nat Immunol (2000) 3.58

Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-beta precursor protein and amyloidogenic A beta peptide formation. Cell (1999) 3.58

Should nurse practitioners play a larger role in Canada's health care system? CMAJ (1992) 3.41

Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families. Nat Genet (1994) 3.38

Randomized clinical trial of early laparoscopy in the management of acute non-specific abdominal pain. Br J Surg (1999) 3.18

Women prefer hospital births. BMJ (1992) 2.88

Experiences in Hong Kong with the theory and practice of the albumin column method of sperm separation for sex selection. Hum Reprod (1998) 2.87

Energy efficient medium access protocol for wireless medical body area sensor networks. IEEE Trans Biomed Circuits Syst (2008) 2.75

Identification of redox/repair protein Ref-1 as a potent activator of p53. Genes Dev (1997) 2.70

Cerebral pathways for calculation: double dissociation between rote verbal and quantitative knowledge of arithmetic. Cortex (1997) 2.64

A randomised prospective trial of intra-operative oesophageal Doppler-guided fluid administration in major gynaecological surgery. Anaesthesia (2013) 2.63

Synergism between subpopulations of thymus-derived cells mediating the proliferative and effector phases of the mixed lymphocyte reaction. Proc Natl Acad Sci U S A (1973) 2.48

Functional interchangeability of DNA replication genes in Salmonella typhimurium and Escherichia coli demonstrated by a general complementation procedure. Genetics (1984) 2.42

Controlled-drinking advocates challenge use of abstinence model in treatment of addiction. CMAJ (1993) 2.41

Letter binding and invariant recognition of masked words: behavioral and neuroimaging evidence. Psychol Sci (2004) 2.41

The Ottawa Heart Institute: it's good, but can we afford it? CMAJ (1990) 2.35

Abstract representations of numbers in the animal and human brain. Trends Neurosci (1998) 2.31

The mental representation of hand movements after parietal cortex damage. Science (1996) 2.28

The DAF-3 Smad protein antagonizes TGF-beta-related receptor signaling in the Caenorhabditis elegans dauer pathway. Genes Dev (1997) 2.26

Multiple shunt failures: an analysis of relevant factors. Childs Nerv Syst (1998) 2.25

Evidence of limited variability of antigen receptors on intrathyroidal T cells in autoimmune thyroid disease. N Engl J Med (1991) 2.21

Low-molecular-weight heparin for the treatment of acute ischemic stroke. N Engl J Med (1995) 2.17

Short-term effectiveness of anticipatory guidance to reduce early childhood risks for subsequent violence. Arch Pediatr Adolesc Med (1997) 2.15

Pharmacologic management of psychiatric illness during pregnancy: dilemmas and guidelines. Am J Psychiatry (1996) 2.14

A randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal carcinoma. J Clin Oncol (1988) 2.14

Using a birth cohort to study ageing: representativeness and response rates in the National Survey of Health and Development. Eur J Ageing (2013) 2.12

Influence of pH on vaginal discharges. Br J Vener Dis (1969) 2.12

The cortical representation of speech. J Cogn Neurosci (1993) 2.12

Increased expression and cellular localization of inducible nitric oxide synthase and cyclooxygenase 2 in Helicobacter pylori gastritis. Gastroenterology (1999) 2.04

Arginine deiminase system and bacterial adaptation to acid environments. Appl Environ Microbiol (1987) 2.03

Can physicians afford not to get involved in hospital administration? CMAJ (1992) 2.03

Breaking bad news about cancer: patients' preferences for communication. J Clin Oncol (2001) 2.00

Differential contributions of the left and right inferior parietal lobules to number processing. J Cogn Neurosci (1999) 1.98

Transformation of group F streptococci by plasmid DNA. J Gen Microbiol (1978) 1.97

Physical and psychological morbidity after axillary lymph node dissection for breast cancer. J Clin Oncol (1999) 1.96

'Alternative cancer cures': looking for common ground. Lancet Oncol (2000) 1.95

Methods utilizing cell-free protein-synthesizing systems for the identification of recombinant DNA molecules. Methods Enzymol (1983) 1.94

Individual differences in allocation of funds in the dictator game associated with length of the arginine vasopressin 1a receptor RS3 promoter region and correlation between RS3 length and hippocampal mRNA. Genes Brain Behav (2007) 1.86

A comprehensive analysis of high school genetics standards: are states keeping pace with modern genetics? CBE Life Sci Educ (2011) 1.80

Minimal access approach to the management of large ovarian cysts. Surg Endosc (2006) 1.78

Cell death attenuation by 'Usurpin', a mammalian DED-caspase homologue that precludes caspase-8 recruitment and activation by the CD-95 (Fas, APO-1) receptor complex. Cell Death Differ (1998) 1.76

Anatomical variability in the cortical representation of first and second language. Neuroreport (1997) 1.74

Meta-analysis of treatment termination rates among rheumatoid arthritis patients receiving disease-modifying anti-rheumatic drugs. Rheumatology (Oxford) (2000) 1.64

Assessment of the validity of the INR system for patients with liver impairment. Thromb Haemost (1994) 1.63

Understanding dissociations in dyscalculia: a brain imaging study of the impact of number size on the cerebral networks for exact and approximate calculation. Brain (2000) 1.63

Complete surgical excision is effective treatment for children with immature teratomas with or without malignant elements: A Pediatric Oncology Group/Children's Cancer Group Intergroup Study. J Clin Oncol (1999) 1.61

Transcranial magnetic stimulation for the treatment of seizures: a controlled study. Neurology (2002) 1.59

Role of the human motor cortex in rapid motor learning. Exp Brain Res (2001) 1.58

The association of obesity with infertility and related menstural abnormalities in women. Int J Obes (1979) 1.57

Farnesyl pyrophosphate synthase is the molecular target of nitrogen-containing bisphosphonates. Biochem Biophys Res Commun (1999) 1.54

Choreoathetosis after deep hypothermia without circulatory arrest. Ann Thorac Surg (1990) 1.51

Preoperative concurrent 5-fluorouracil infusion, mitomycin C and pelvic radiation therapy in tethered and fixed rectal carcinoma. Int J Radiat Oncol Biol Phys (1993) 1.51

Reliability and validity of three-dimensional fetal brain volumes. J Ultrasound Med (2001) 1.50

Mutations in the catalase-peroxidase gene from isoniazid-resistant Mycobacterium tuberculosis isolates. J Infect Dis (1994) 1.50

Genetic contamination of Dahl SS/Jr rats. Impact on studies of salt-sensitive hypertension. Hypertension (1994) 1.48

Oral capecitabine as an alternative to i.v. 5-fluorouracil-based adjuvant therapy for colon cancer: safety results of a randomized, phase III trial. Ann Oncol (2003) 1.48

Functional MR evaluation of temporal and frontal language dominance compared with the Wada test. Neurology (2000) 1.48

Capecitabine versus 5-fluorouracil/folinic acid as adjuvant therapy for stage III colon cancer: final results from the X-ACT trial with analysis by age and preliminary evidence of a pharmacodynamic marker of efficacy. Ann Oncol (2011) 1.47

Strains of Streptococcus mutans and Streptococcus sobrinus attach to different pellicle receptors. Infect Immun (1986) 1.46

Quality of life in HIV-infected women in the south-eastern United States. AIDS Care (1997) 1.46

A redox factor protein, ref1, is involved in negative gene regulation by extracellular calcium. J Biol Chem (1994) 1.46

Synergism between distinct enhanson domains in viral induction of the human beta interferon gene. Mol Cell Biol (1990) 1.46

Use of transcranial Doppler ultrasound to predict outcome in patients with intracranial large-artery occlusive disease. Stroke (2000) 1.46

Outcome after temporary vascular occlusion for the management of renal trauma. J Urol (1994) 1.44

Risk of endometrial carcinoma associated with BRCA mutation. Gynecol Oncol (2001) 1.42

Generation of an integrated transcription map of the BRCA2 region on chromosome 13q12-q13. Genomics (1996) 1.41

Control and intrusive memories as possible determinants of chronic stress. Psychosom Med (1993) 1.40

Salivary gland enlargement and phenylbutazone. Br Med J (1966) 1.40

Why are Canada's nurses quitting? CMAJ (1989) 1.39

Activation of AP-1 and of a nuclear redox factor, Ref-1, in the response of HT29 colon cancer cells to hypoxia. Mol Cell Biol (1994) 1.39

[Post-lumbar puncture syndrome. Causes, prevention, treatments]. Rev Neurol (Paris) (1997) 1.39

Canada's blood collection system should be reorganized, critics say. CMAJ (1990) 1.39

Cerebral activations during number multiplication and comparison: a PET study. Neuropsychologia (1996) 1.39

Brain processing of native and foreign languages. Neuroreport (1996) 1.38

Hospital utilization and inpatient care. Isr Med Assoc J (2001) 1.38

Bcl-xL functions downstream of caspase-8 to inhibit Fas- and tumor necrosis factor receptor 1-induced apoptosis of MCF7 breast carcinoma cells. J Biol Chem (1998) 1.38

Co-localization of the myelin-associated glycoprotein and the microfilament components, F-actin and spectrin, in Schwann cells of myelinated nerve fibres. J Neurocytol (1989) 1.37

Structure and expression of ferritin genes in a human promyelocytic cell line that differentiates in vitro. Mol Cell Biol (1986) 1.37

Cleavage of plasma membrane calcium pumps by caspases: a link between apoptosis and necrosis. Cell Death Differ (2002) 1.36

Cloning, sequencing and disruption of a gene from Streptomyces clavuligerus involved in clavulanic acid biosynthesis. Gene (1994) 1.36

The human A33 antigen is a transmembrane glycoprotein and a novel member of the immunoglobulin superfamily. Proc Natl Acad Sci U S A (1997) 1.36

Alzheimer's disease--synergistic effects of glucose deficit, oxidative stress and advanced glycation endproducts. J Neural Transm (Vienna) (1998) 1.35

Characterization of a DNA probe for detection of Mycobacterium tuberculosis complex in clinical samples by polymerase chain reaction. J Clin Microbiol (1992) 1.34

Copper versus the gonococcus in vivo. Br J Vener Dis (1974) 1.34

Cognitive impairment and functional outcome after stroke associated with small vessel disease. J Neurol Neurosurg Psychiatry (2004) 1.33

Quinidine-induced action potential prolongation, early afterdepolarizations, and triggered activity in canine Purkinje fibers. Effects of stimulation rate, potassium, and magnesium. Circulation (1989) 1.32

Isolation and partial characterization of Fc gamma-binding proteins of human leukocytes. J Clin Invest (1981) 1.31

Restricted T-cell receptor V beta gene usage by myelin basic protein-specific T-cell clones in multiple sclerosis: predominant genes vary in individuals. Proc Natl Acad Sci U S A (1991) 1.31

Prospective randomised evaluation of traditional Chinese medicine combined with chemotherapy: a randomised phase II study of wild toad extract plus gemcitabine in patients with advanced pancreatic adenocarcinomas. Br J Cancer (2012) 1.31

Relative importance of pyruvate dehydrogenase interconversion and feed-back inhibition in the effect of fatty acids on pyruvate oxidation by rat heart mitochondria. Arch Biochem Biophys (1978) 1.30

Congruent unilateral impairments for real and imagined hand movements. Neuroreport (1995) 1.30